Spots Global Cancer Trial Database for oblimersen
Every month we try and update this database with for oblimersen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors | NCT00636545 | Solid Tumors | Oblimersen (Gen... Oblimersen (Gen... | 18 Years - | Genta Incorporated | |
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma | NCT01200342 | Melanoma | Genasense Paclitaxel Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma | NCT01200342 | Melanoma | Genasense Paclitaxel Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma | NCT00518895 | Melanoma | dacarbazine plu... dacarbazine plu... | 18 Years - | Genta Incorporated | |
Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia | NCT00078234 | Chronic Lymphoc... | Oblimersen-ritu... | 18 Years - | Genta Incorporated | |
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma | NCT00518895 | Melanoma | dacarbazine plu... dacarbazine plu... | 18 Years - | Genta Incorporated |